Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies
about
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes MellitusUse of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes.HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionEarly prediction of autoimmune (type 1) diabetes.Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility StudyCompromised central tolerance of ICA69 induces multiple organ autoimmunity.The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes.Prediction of type 1 diabetesHLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patientsGeorge S. Eisenbarth: insulin and type 1 diabetes.Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's diseaseCharacteristics of maturity onset diabetes of the young in a large diabetes center.The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsThe relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants.The Role of Laboratory Testing in Differentiating Type 1 Diabetes from Type 2 Diabetes in Patients Undergoing Bariatric Surgery.Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes.Predictors of slow progression to diabetes in children with multiple islet autoantibodies.Therapeutic targeting of B cells and T cells in autoimmune diabetes: is it a solution?Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults.Use of self-collected capillary blood samples for islet autoantibody screening in relatives: a feasibility and acceptability study.Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease.A subclass of serum anti-ZnT8 antibodies directed to the surface of live pancreatic β-cells.Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.Zinc transporter 8 autoantibodies: what is their clinical relevance in gestational diabetes?A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease.β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis
P2860
Q26796516-3E4C7C25-5F10-436F-AC4C-48819D53093FQ30574604-55BD4786-9193-4968-9FE5-71D9CD59C9A8Q30732418-6909CF1D-6CD7-475A-92E5-2DA209D71B04Q33854613-B2176095-4958-47C2-9C4A-A6ABFEAB7BB9Q34762316-0ECAD04B-6501-434F-8CEE-6F547EECE4E3Q35064081-752D2052-3098-4A27-8215-82BFB5CFC2FBQ35674747-4D20594C-DE9F-4E0B-B77A-CDEFE909ACA6Q36335960-126F404D-DE0C-49AC-B86E-0FF7B4887DB4Q36348307-3C6BB5E3-D5BB-46DC-96DD-A95FBB66630CQ36366718-DFA5D480-51A0-4E9E-B563-0D926F2BF8BFQ36440605-86B8FFBE-0BA1-4B97-8F3D-0C2434025AAFQ36547636-FBE87241-8FB1-42DA-A898-05B00D2768C1Q36720573-CEBC25E9-AFFC-4F6B-B45D-C7041B9A81F5Q36720640-0E8B3ABC-9D85-42DD-907A-2E3995672C47Q36868176-B347F752-F8A1-449B-BA29-64B15019F379Q36932173-BD7563F5-43F6-4D11-ABC3-9C10C9D0B5BDQ36990055-18666D4E-458D-428D-B8E7-07D7ED1B8480Q37068285-EEBB682C-F218-44C8-A066-C3529BCDC52EQ37106456-B0BE01EB-C1AA-45F9-8D0B-720CF46A61EFQ37368421-1CDAEB20-3330-42DE-88C4-5542E99F672AQ40127909-8BAB22E4-D63C-45C8-916C-5C958A774772Q41751849-E276C0EC-8FD5-4C45-A7C8-61FC324312FEQ42407419-1A41A764-5F65-4DBA-B94D-582C4C0F3F15Q42869996-88DDDD31-B1F4-4FA3-9383-C1514D122FF1Q44972607-A2B8854E-80BC-4221-A7BE-C68934DC7AB7Q46115645-20CC51C5-667E-46DE-8F85-CA6B6D57FB36Q46140989-CCC82408-9326-40ED-8C27-56FD0C97FBCBQ46187230-F9F5361C-4577-4411-A0E1-197A148CB2ACQ47626653-D126998C-5AF4-433F-93CD-6E9633D4D9B1Q49566480-9ACA31E9-BAEE-4E79-BD5B-61D920429B18Q50988456-0F904339-972E-4706-958E-C42CF25BC299Q51312898-212D924C-AD93-4EEF-87FA-729B63E3BD1AQ53199203-6FBD3173-9143-4E85-A28A-9768B19E5455Q58792346-A3FDA876-C401-4367-A062-21301991E037
P2860
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Zinc transporter-8 autoantibod ...... ard biochemical autoantibodies
@ast
Zinc transporter-8 autoantibod ...... ard biochemical autoantibodies
@en
type
label
Zinc transporter-8 autoantibod ...... ard biochemical autoantibodies
@ast
Zinc transporter-8 autoantibod ...... ard biochemical autoantibodies
@en
prefLabel
Zinc transporter-8 autoantibod ...... ard biochemical autoantibodies
@ast
Zinc transporter-8 autoantibod ...... ard biochemical autoantibodies
@en
P2093
P2860
P356
P1433
P1476
Zinc transporter-8 autoantibod ...... ard biochemical autoantibodies
@en
P2093
Carla J Greenbaum
Craig A Beam
David C Boulware
George S Eisenbarth
Janet M Wenzlau
Jay M Sosenko
Jay S Skyler
Jeffrey L Mahon
Jeffrey P Krischer
John C Hutton
P2860
P304
P356
10.2337/DC11-2081
P407
P577
2012-03-23T00:00:00Z